HGH 191AA (Somatotropin)
HGH 191AA, also known as Somatotropin, is a bio-identical synthetic version of human growth hormone containing exactly 191 amino acids. Research demonstrates its critical role in cellular regeneration, growth, metabolism, and maintaining healthy human tissue throughout the lifespan.
01Dosing reference
02Mechanism of action
Receptor Binding
Binds directly to growth hormone receptors (GHR) located on the surface of target cells across various tissues.
IGF-1 Stimulation
Stimulates the liver and other tissues to secrete Insulin-like Growth Factor 1 (IGF-1), which mediates many of its systemic effects.
Metabolic and Anabolic Action
Promotes lipolysis (fat breakdown), increases protein synthesis, and stimulates the growth of bone and cartilage.
03Human evidence
Significant improvement in body composition, including increased lean body mass and decreased fat mass, in adults with growth hormone deficiency.
Multiple randomized controlled trials in adults diagnosed with severe GH deficiency.
Increased bone mineral density and reduced fracture risk over long-term replacement therapy.
Longitudinal studies tracking patients on GH replacement therapy for up to 10-15 years.
04Preclinical evidence
Enhanced tissue regeneration and wound healing in various injury models.
Animal models of severe burns and surgical wounds.
Neuroprotective effects and promotion of neurogenesis in the central nervous system.
Rodent models investigating brain injury and age-related cognitive decline.
05What is known vs. unknown
- Bio-identical to the naturally occurring growth hormone produced by the human pituitary gland.
- Acts both directly on tissues and indirectly through the stimulation of IGF-1.
- Clinically proven to treat growth hormone deficiency in both pediatric and adult populations.
- Known to improve lipid profiles and cardiovascular risk markers in deficient individuals.
- The long-term safety of supraphysiological doses used for anti-aging or performance enhancement remains poorly documented.
- The exact relationship between long-term exogenous GH use and the risk of developing certain neoplasms (cancers) is still debated.
06Safety & regulatory context
07Compared with Ipamorelin
08Glossary
09Knowledge check
10Sources
More in Growth Hormone
Sermorelin
Sermorelin is a synthetic peptide consisting of the first 29 amino acids of naturally occurring growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to naturally produce and release human growth hormone (hGH), making it a subject of research for age-related growth hormone decline, body composition, and vitality.
Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to secrete growth hormone. It is FDA-approved for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy and is being researched for potential cognitive benefits.
Hexarelin
Hexarelin is a potent, synthetic hexapeptide and growth hormone secretagogue (GHS) that stimulates the release of growth hormone. Research indicates it is one of the strongest GH-releasing peptides available, offering potential benefits for muscle growth, fat loss, and cardiovascular health without significantly increasing appetite.